Instadose Pharma Corp. (INSD)

USD 0.0

(0.0%)

Revenue Summary of Instadose Pharma Corp.

  • Instadose Pharma Corp.'s latest annual revenue in 2023 was - USD , down 0.0% from previous year.
  • Instadose Pharma Corp.'s latest quarterly revenue in 2024 Q1 was - USD , down 0.0% from previous quarter.
  • Instadose Pharma Corp. reported a annual revenue of - USD in annual revenue 2022, down 0.0% from previous year.
  • Instadose Pharma Corp. reported a annual revenue of - USD in annual revenue 2021, down 0.0% from previous year.
  • Instadose Pharma Corp. reported a quarterly revenue of - USD for 2023 Q3, down 0.0% from previous quarter.
  • Instadose Pharma Corp. reported a quarterly revenue of - USD for 2023 FY, down 0.0% from previous quarter.

Annual Revenue Chart of Instadose Pharma Corp. (2023 - 2017)

Historical Annual Revenue of Instadose Pharma Corp. (2023 - 2017)

Year Revenue Revenue Growth
2023 - USD 0.0%
2022 - USD 0.0%
2021 - USD 0.0%
2020 - USD -100.0%
2019 3604.87 USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%

Peer Revenue Comparison of Instadose Pharma Corp.

Name Revenue Revenue Difference
Bright Green Corporation 401.49 Thousand USD 100.0%
BioQuest Corp. - USD NaN%
Clever Leaves Holdings Inc. 17.41 Million USD 100.0%
Eagle Pharmaceuticals, Inc. 316.61 Million USD 100.0%
Guardion Health Sciences, Inc. 12.24 Million USD 100.0%
GSRX Industries Inc. - USD NaN%
High Sierra Technologies, Inc. - USD NaN%